Trial Profile
A phase II study of combination chemotherapy with carboplatin plus S-1 in advanced and recurrence non small cell lung cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Mar 2017
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 09 Mar 2013 New trial record